ID
22440
Beschrijving
ODM derived from http://clinicaltrials.gov/show/NCT00185393
Link
http://clinicaltrials.gov/show/NCT00185393
Trefwoorden
Versies (2)
- 09-12-11 09-12-11 -
- 04-06-17 04-06-17 - Martin Dugas
Geüploaded op
4 juni 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy
Eligibility
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beschrijving
other anticancer treatment
Datatype
boolean
Alias
- UMLS CUI [1]
- C0478584
Beschrijving
Prior radiation therapy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0279134
Beschrijving
no recovery from chemotherapy
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1709277
- UMLS CUI [1,2]
- C0392920
Beschrijving
other cancer
Datatype
boolean
Alias
- UMLS CUI [1]
- C1707251
Beschrijving
HIV
Datatype
boolean
Alias
- UMLS CUI [1]
- C0019682
Beschrijving
pleural effusion or ascites
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0032227
- UMLS CUI [1,2]
- C0003962
Beschrijving
pregnant or breast feeding
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0032961
- UMLS CUI [1,2]
- C0006147
Beschrijving
no contraception
Datatype
boolean
Alias
- UMLS CUI [1]
- C2919192
Beschrijving
non-compliance
Datatype
boolean
Alias
- UMLS CUI [1]
- C0457432
Similar models
Eligibility
- StudyEvent: Eligibility
C0280116 (UMLS CUI [1,2])
C0280117 (UMLS CUI [1,3])
C2045825 (UMLS CUI [1,2])
C1442456 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,2])
C0003962 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])